Maria Serra-Blasco

ORCID: 0000-0001-5793-9906
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Functional Brain Connectivity Studies
  • Treatment of Major Depression
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Mental Health Research Topics
  • Schizophrenia research and treatment
  • Cancer survivorship and care
  • Tryptophan and brain disorders
  • Bipolar Disorder and Treatment
  • Neurological disorders and treatments
  • Transcranial Magnetic Stimulation Studies
  • Cancer-related cognitive impairment studies
  • Advanced Neuroimaging Techniques and Applications
  • Advanced MRI Techniques and Applications
  • Obsessive-Compulsive Spectrum Disorders
  • Dementia and Cognitive Impairment Research
  • Neural and Behavioral Psychology Studies
  • Stress Responses and Cortisol
  • Suicide and Self-Harm Studies
  • Mindfulness and Compassion Interventions
  • Parkinson's Disease Mechanisms and Treatments
  • Electroconvulsive Therapy Studies
  • Health and Well-being Studies
  • Ophthalmology and Visual Health Research
  • Cognitive Functions and Memory
  • Digital Mental Health Interventions

Institut d'Investigació Biomédica de Bellvitge
2023-2025

Institut Català d'Oncologia
2021-2025

Centro de Investigación Biomédica en Red de Salud Mental
2014-2025

Bellvitge University Hospital
2025

Instituto de Salud Carlos III
2021-2025

Universitat Oberta de Catalunya
2024

Institut Català d'Ornitologia
2024

College of the Holy Cross
2024

Centro de Investigación Biomédica en Red
2013-2024

Universitat Abat Oliba CEU
2021-2023

Deep brain stimulation (DBS) is currently tested as an experimental therapy for patients with treatment-resistant depression (TRD). Here we report on the short- and long-term (1 yr) clinical outcomes tolerance of DBS in eight TRD patients. Electrodes were implanted bilaterally subgenual cingulate gyrus (SCG; Broadman areas 24-25), stimulated at 135 Hz (90-μs pulsewidth). Voltage active electrode contacts adjusted to maximize short-term responses. Clinical assessments included 17-item...

10.1017/s1461145711001088 article EN The International Journal of Neuropsychopharmacology 2011-07-22

Background Although white-matter abnormalities have been reported in middle-aged patients with major depressive disorder (MDD), few data are available on treatment-resistant MDD and the influence of relevant variables related to clinical burden illness is far from being well established. Method The present study examined microstructure a sample 52 different stages (treatment-resistant/chronic MDD, n = 18; remitted-recurrent 15; first-episode 19) 17 healthy controls, using diffusion tensor...

10.1017/s003329171300158x article EN Psychological Medicine 2013-08-21

<h3>Background:</h3> Smaller hippocampal volumes in major depressive disorder (MDD) have been linked with earlier onset, previous recurrences and treatment refractoriness. The aim of our study was to investigate metabolite abnormalities the hippocampus associated past illness burden. <h3>Methods:</h3> Glutamate/glutamine (Glx), <i>N</i>-acetylaspartate (NAA) choline (Cho), potential markers glial/neuronal integrity membrane turnover, respectively, were measured adults depression healthy...

10.1503/jpn.110185 article EN Journal of Psychiatry and Neuroscience 2013-02-20

Findings of brain structural changes in major depressive disorder are still inconsistent, partly because some crucial clinical variables have not been taken into account.To investigate the effect on grey matter volumes.Voxel-based morphometry was used to compare 66 patients with depression at different illness stages (22 each first-episode, remitted-recurrent and treatment resistant/chronic depression) 32 healthy controls. Brain volumes were correlated variables.Voxel-based showed a...

10.1192/bjp.bp.112.116228 article EN The British Journal of Psychiatry 2013-04-26

Abstract: Exposure to acute and chronic stress has a broad range of structural effects on the brain. The brain areas commonly targeted in response models include hippocampus, amygdala, prefrontal cortex. Studies patients suffering from so-called stress-related disorders -embracing post-traumatic stress, major depressive anxiety disorders- have fairly replicated animal -particularly neuroendocrine inflammatory models- by finding alterations different areas, even early neurodevelopment....

10.2174/1570159x21666230703091435 article EN cc-by Current Neuropharmacology 2023-07-05

Background Action mechanisms of therapeutic alliance in stepped and digital interventions remain unclear. Aims (a) To compare the development between psychosocial treatment as usual (PTAU) a intervention designed to prevent distress cancer patients; (b) analyse level agreement patients’ therapists’ ratings; (c) explore variables associated with intervention. Method A multicentre randomised controlled trial 184 newly diagnosed breast women was conducted. Patients were assigned or PTAU....

10.1192/bjo.2024.844 article EN cc-by-nc-nd BJPsych Open 2025-01-01

Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, has demonstrated efficacy in improving affective symptoms of Major Depressive Disorder (MDD); however, its effects on associated cognitive and functional difficulties remain underexplored. This study seeks to assess the antidepressant desvenlafaxine patients with SSRI-resistant MDD, impact both objective subjective performance, where improvements occur independently clinical recovery or not, influence psychosocial functioning. An...

10.1186/s12991-025-00552-2 article EN cc-by-nc-nd Annals of General Psychiatry 2025-03-19

Background: Childhood maltreatment increases the risk of suicide attempts in general population, possibly having similar effects among patients with major depressive disorder (MDD). The few studies that have addressed this association been restricted to specific populations (e.g. treatment-resistant depression, personality disorders) and rarely taken sex into account. Objective: To examine impact childhood on MDD above beyond other factors potential confounders, while considering...

10.1080/20008198.2019.1603557 article EN cc-by-nc European journal of psychotraumatology 2019-05-07

Bipolar disorder (BD) is characterized by episodic mood dysregulation, although a significant portion of patients suffer persistent cognitive impairment during euthymia. Previous magnetic resonance imaging (MRI) research suggests BD may have accelerated brain aging, observed as lower grey matter volumes. How these neurostructural alterations are related to the profile unclear.

10.1016/j.pnpbp.2024.110962 article EN cc-by-nc-nd Progress in Neuro-Psychopharmacology and Biological Psychiatry 2024-02-15

Virtual Reality (VR) is considered an effective way to boost empathy by adopting the perspective of others, thus having clear potential for improving anti-bullying programs. However, this benefit VR limited both lack adequate content and empirical evidence its effectiveness. In article, we present process co-creation a set 360°-videos representing experience victims bullying from first-person perspective, involving secondary school students (N = 89). The impact presentation in terms...

10.1016/j.compedu.2020.104065 article EN cc-by-nc-nd Computers & Education 2020-10-28

Impairment of social cognition is documented in bipolar disorder (BD) and schizophrenia/schizoaffective (SCH). In healthy individuals, women perform better than men some its sub-domains. However, BD SCH the results are mixed. Our aim was to compare emotion recognition, affective Theory Mind (ToM) first- second-order cognitive ToM BD, subjects, investigate sex-related differences.120 patients (BD = 60, 60) 40 subjects were recruited. Emotion recognition assessed by Pictures Facial Affect...

10.1016/j.comppsych.2021.152258 article EN cc-by-nc-nd Comprehensive Psychiatry 2021-07-05

Environmental factors such as psychosocial stress have demonstrated to an impact on the breast cancer (BC) course. This study aims explore of psychotherapy and stressful life events (SLE) BC survivors' illness trajectories. 68 women with underwent Positive Psychotherapy or Cognitive-Behavioral Stress Management 37 patients were included a control group. The effects distress reduction SLE their 5-year recurrence investigated. Additional analyses examined effect receiving vs. not type therapy...

10.1016/j.ijchp.2022.100303 article EN cc-by-nc-nd International Journal of Clinical and Health Psychology 2022-04-01

Abstract Background Heterogeneity in cognitive functioning among major depressive disorder (MDD) patients could have been the reason for small-to-moderate differences reported so far when it is compared to other psychiatric conditions or healthy controls. Additionally, most of these studies did not take into account clinical and sociodemographic characteristics that played a relevant role variability. This study aims identify empirical clusters based on cognitive, variables sample acute MDD...

10.1017/s0033291720001567 article EN cc-by Psychological Medicine 2020-06-01

This study aimed to identify clinical and cognitive factors associated with increased risk for difficult-to-treat depression (DTD) or treatment-resistant (TRD).

10.1192/j.eurpsy.2020.65 article EN cc-by-nc-nd European Psychiatry 2020-01-01

Despite its high recurrence rate, major depression disorder (MDD) still lacks neurobiological markers to optimize treatment selection. The aim of this study was examine the prognostic potential clinical and structural magnetic resonance imaging (sMRI) in long-term MDD outcomes (COs).Forty-nine patients were grouped into one four different CO categories according their trajectory: recovery, partial remission, remission recurrence, chronic depression. Regression models including baseline...

10.1002/da.22522 article EN Depression and Anxiety 2016-05-09
Coming Soon ...